Clinical Trials
4 trialsNCT06893354 2025-03-25
Explore the Mechanisms Underlying Disease Resistance and Potential Primary Resistance Mechanism of Induction Therapy Lorlatinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harboring ALK Positive Mutation Revealed by Single-cell RNA Sequencing and Spatial Transcriptomics
The First Affiliated Hospital of Guangzhou Medical University
Phase 4 Not yet recruiting
NCT05098990 2021-10-29
Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Phase 4 Unknown
NCT03986528 2021-02-23
Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phase 4 Unknown
NCT02000531 2016-01-13
Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population
Hoffmann-La Roche
Phase 4 Completed